Test ID BLOD1048 Follicle-Stimulating Hormone (FSH), Serum
Useful For
An adjunct in the evaluation of menstrual irregularities
Evaluating patients with suspected hypogonadism
Predicting ovulation
Evaluating infertility
Diagnosing pituitary disorders
Specimen Type
SerumSpecimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.6 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial within 2 hours of collection.
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | Reject |
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 180 days | ||
Ambient | 24 hours |
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysMethod Name
Electrochemiluminescence Immunoassay
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
83001
Reporting Name
Follicle-Stim Hormone (FSH), SReference Values
Males
<12 months: ≤3.3 IU/L
12 months-5 years: ≤1.9 IU/L
>5 years-10 years: ≤2.3 IU/L
>10 years-15 years: 0.6-6.9 IU/L
>15 years-18 years: 0.7-9.6 IU/L
>18 years: 1.2-15.8 IU/L
TANNER STAGES*
Stage l: <1.5 IU/L
Stage ll: <3.0 IU/L
Stage lll: 0.4-6.2 IU/L
Stage lV: 0.6-5.1 IU/L
Stage V: 0.8-7.2 IU/L
*Puberty onset occurs for boys at a median age of 11.5 (± 2) years. For boys, there is no proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage V (adult) should be reached by age 18.
Females
<12 months: 1.2-12.5 IU/L
12 months-10 years: 0.5-6.0 IU/L
>10 years-15 years: 0.9-8.9 IU/L
>15 years-18 years: 0.7-9.6 IU/L
Premenopausal:
Follicular: 2.9-14.6 IU/L
Midcycle: 4.7-23.2 IU/L
Luteal: 1.4-8.9 IU/L
Postmenopausal: 16.0-157.0 IU/L
TANNER STAGES*
Stage l: 0.6-4.1 IU/L
Stage ll: 0.3-5.8 IU/L
Stage lll: 0.1-7.2 IU/L
Stage lV: 0.3-7.0 IU/L
Stage V: 0.4-8.6 IU/L
*Puberty onset (transition from Tanner stage I to Tanner stage II) occurs for girls at a median age of 10.5 (± 2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African American girls. Progression through Tanner stages is variable. Tanner stage V (adult) should be reached by age 18.
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.Forms
If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.
Secondary ID
602753SANFORD LABORATORY INTERFACE BUILD INFORMATION
Result Code | Result Code Description |
---|---|
20218 | FSH with Tanner Stages |